RaQualia Pharma Inc. (TYO:4579)

RaQualia Pharma Revenue

RaQualia Pharma had revenue of 569.59M JPY in the quarter ending June 30, 2025, a decrease of -25.35%. This brings the company's revenue in the last twelve months to 3.23B, up 40.60% year-over-year. In the year 2024, RaQualia Pharma had annual revenue of 3.11B with 63.44% growth.

• Revenue (ttm): 3.23B
• Revenue Growth: +40.60%
• P/S Ratio: 4.16
• Revenue / Employee: 50.48M
• Employees: 64
• Market Cap: 13.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.11B	1.21B	63.44%
Dec 31, 2023	1.90B	-1.02B	-34.85%
Dec 31, 2022	2.92B	142.00M	5.12%
Dec 31, 2021	2.78B	1.67B	150.77%
Dec 31, 2020	1.11B	-595.00M	-34.96%